Cargando…

Troponin T Is Negatively Associated With 3 Tesla Magnetic Resonance Peripheral Nerve Perfusion in Type 2 Diabetes

OBJECTIVE: The pathogenesis of diabetic polyneuropathy (DN) is poorly understood and given the increasing prevalence of DN, there is a need for clinical or imaging biomarkers that quantify structural and functional nerve damage. While clinical studies have found evidence of an association between el...

Descripción completa

Detalles Bibliográficos
Autores principales: Jende, Johann M. E., Mooshage, Christoph, Kender, Zoltan, Schimpfle, Lukas, Juerchott, Alexander, Nawroth, Peter, Heiland, Sabine, Bendszus, Martin, Kopf, Stefan, Kurz, Felix T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127234/
https://www.ncbi.nlm.nih.gov/pubmed/35620394
http://dx.doi.org/10.3389/fendo.2022.839774
_version_ 1784712306237636608
author Jende, Johann M. E.
Mooshage, Christoph
Kender, Zoltan
Schimpfle, Lukas
Juerchott, Alexander
Nawroth, Peter
Heiland, Sabine
Bendszus, Martin
Kopf, Stefan
Kurz, Felix T.
author_facet Jende, Johann M. E.
Mooshage, Christoph
Kender, Zoltan
Schimpfle, Lukas
Juerchott, Alexander
Nawroth, Peter
Heiland, Sabine
Bendszus, Martin
Kopf, Stefan
Kurz, Felix T.
author_sort Jende, Johann M. E.
collection PubMed
description OBJECTIVE: The pathogenesis of diabetic polyneuropathy (DN) is poorly understood and given the increasing prevalence of DN, there is a need for clinical or imaging biomarkers that quantify structural and functional nerve damage. While clinical studies have found evidence of an association between elevated levels of troponin T (hsTNT) and N-terminal pro brain natriuretic peptide (proBNP) with microvascular compromise in type 2 diabetes (T2D), their implication in mirroring DN nerve perfusion changes remains unclear. The objective of this study was, therefore, to investigate whether hsTNT and proBNP assays are associated with MRI nerve perfusion in T2D. METHODS: In this prospective cross-sectional single-center case-control study, 56 participants (44 with T2D, 12 healthy control subjects) consented to undergo magnetic resonance neurography (MRN) including dynamic contrast-enhanced (DCE) perfusion imaging of the right leg. Using the extended Tofts model, primary outcome parameters that were quantified are the sciatic nerve’s microvascular permeability (K(trans)), the extravascular extracellular volume fraction (v(e)), and the plasma volume fraction (v(p)), as well as hsTNT and proBNP values from serological workup. Further secondary outcomes were clinical, serological, and electrophysiological findings. RESULTS: In T2D patients, hsTNT was negatively correlated with K(trans) (r=-0.38; p=0.012) and v(e) (r=-0.30; p=0.048) but not with v(p) (r=-0.16; p=0.294). HsTNT, K(trans), and v(e) were correlated with peroneal nerve conduction velocities (NCVs; r=-0.44; p=0.006, r=0.42; p=0.008, r=0.39; p=0.014), and tibial NCVs (r=-0.38;p=0.022, r=0.33; p=0.048, r=0.37; p=0.025). No such correlations were found for proBNP. CONCLUSIONS: This study is the first to find that hsTNT is correlated with a decrease of microvascular permeability and a reduced extravascular extracellular volume fraction of nerves in patients with T2D. The results indicate that hsTNT may serve as a potential marker for the assessment of nerve perfusion in future studies on DN.
format Online
Article
Text
id pubmed-9127234
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-91272342022-05-25 Troponin T Is Negatively Associated With 3 Tesla Magnetic Resonance Peripheral Nerve Perfusion in Type 2 Diabetes Jende, Johann M. E. Mooshage, Christoph Kender, Zoltan Schimpfle, Lukas Juerchott, Alexander Nawroth, Peter Heiland, Sabine Bendszus, Martin Kopf, Stefan Kurz, Felix T. Front Endocrinol (Lausanne) Endocrinology OBJECTIVE: The pathogenesis of diabetic polyneuropathy (DN) is poorly understood and given the increasing prevalence of DN, there is a need for clinical or imaging biomarkers that quantify structural and functional nerve damage. While clinical studies have found evidence of an association between elevated levels of troponin T (hsTNT) and N-terminal pro brain natriuretic peptide (proBNP) with microvascular compromise in type 2 diabetes (T2D), their implication in mirroring DN nerve perfusion changes remains unclear. The objective of this study was, therefore, to investigate whether hsTNT and proBNP assays are associated with MRI nerve perfusion in T2D. METHODS: In this prospective cross-sectional single-center case-control study, 56 participants (44 with T2D, 12 healthy control subjects) consented to undergo magnetic resonance neurography (MRN) including dynamic contrast-enhanced (DCE) perfusion imaging of the right leg. Using the extended Tofts model, primary outcome parameters that were quantified are the sciatic nerve’s microvascular permeability (K(trans)), the extravascular extracellular volume fraction (v(e)), and the plasma volume fraction (v(p)), as well as hsTNT and proBNP values from serological workup. Further secondary outcomes were clinical, serological, and electrophysiological findings. RESULTS: In T2D patients, hsTNT was negatively correlated with K(trans) (r=-0.38; p=0.012) and v(e) (r=-0.30; p=0.048) but not with v(p) (r=-0.16; p=0.294). HsTNT, K(trans), and v(e) were correlated with peroneal nerve conduction velocities (NCVs; r=-0.44; p=0.006, r=0.42; p=0.008, r=0.39; p=0.014), and tibial NCVs (r=-0.38;p=0.022, r=0.33; p=0.048, r=0.37; p=0.025). No such correlations were found for proBNP. CONCLUSIONS: This study is the first to find that hsTNT is correlated with a decrease of microvascular permeability and a reduced extravascular extracellular volume fraction of nerves in patients with T2D. The results indicate that hsTNT may serve as a potential marker for the assessment of nerve perfusion in future studies on DN. Frontiers Media S.A. 2022-05-10 /pmc/articles/PMC9127234/ /pubmed/35620394 http://dx.doi.org/10.3389/fendo.2022.839774 Text en Copyright © 2022 Jende, Mooshage, Kender, Schimpfle, Juerchott, Nawroth, Heiland, Bendszus, Kopf and Kurz https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Jende, Johann M. E.
Mooshage, Christoph
Kender, Zoltan
Schimpfle, Lukas
Juerchott, Alexander
Nawroth, Peter
Heiland, Sabine
Bendszus, Martin
Kopf, Stefan
Kurz, Felix T.
Troponin T Is Negatively Associated With 3 Tesla Magnetic Resonance Peripheral Nerve Perfusion in Type 2 Diabetes
title Troponin T Is Negatively Associated With 3 Tesla Magnetic Resonance Peripheral Nerve Perfusion in Type 2 Diabetes
title_full Troponin T Is Negatively Associated With 3 Tesla Magnetic Resonance Peripheral Nerve Perfusion in Type 2 Diabetes
title_fullStr Troponin T Is Negatively Associated With 3 Tesla Magnetic Resonance Peripheral Nerve Perfusion in Type 2 Diabetes
title_full_unstemmed Troponin T Is Negatively Associated With 3 Tesla Magnetic Resonance Peripheral Nerve Perfusion in Type 2 Diabetes
title_short Troponin T Is Negatively Associated With 3 Tesla Magnetic Resonance Peripheral Nerve Perfusion in Type 2 Diabetes
title_sort troponin t is negatively associated with 3 tesla magnetic resonance peripheral nerve perfusion in type 2 diabetes
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127234/
https://www.ncbi.nlm.nih.gov/pubmed/35620394
http://dx.doi.org/10.3389/fendo.2022.839774
work_keys_str_mv AT jendejohannme troponintisnegativelyassociatedwith3teslamagneticresonanceperipheralnerveperfusionintype2diabetes
AT mooshagechristoph troponintisnegativelyassociatedwith3teslamagneticresonanceperipheralnerveperfusionintype2diabetes
AT kenderzoltan troponintisnegativelyassociatedwith3teslamagneticresonanceperipheralnerveperfusionintype2diabetes
AT schimpflelukas troponintisnegativelyassociatedwith3teslamagneticresonanceperipheralnerveperfusionintype2diabetes
AT juerchottalexander troponintisnegativelyassociatedwith3teslamagneticresonanceperipheralnerveperfusionintype2diabetes
AT nawrothpeter troponintisnegativelyassociatedwith3teslamagneticresonanceperipheralnerveperfusionintype2diabetes
AT heilandsabine troponintisnegativelyassociatedwith3teslamagneticresonanceperipheralnerveperfusionintype2diabetes
AT bendszusmartin troponintisnegativelyassociatedwith3teslamagneticresonanceperipheralnerveperfusionintype2diabetes
AT kopfstefan troponintisnegativelyassociatedwith3teslamagneticresonanceperipheralnerveperfusionintype2diabetes
AT kurzfelixt troponintisnegativelyassociatedwith3teslamagneticresonanceperipheralnerveperfusionintype2diabetes